IceCure Reports 45% Revenue Growth
IceCure Medical Ltd. (NASDAQ: ICCM), a developer of minimally invasive cryoablation technology, reported strong revenue growth for the first half of 2026. Revenue reached $1.818 million, representing a 45% increase from $1.25 million in the first half of 2025. The company attributed the growth to higher sales of its ProSense® systems and disposable probes, alongside…










